5567 studies found for:    Open Studies | "Vascular Diseases"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Unknown  Testosterone for Peripheral Vascular Disease
Conditions: Hypogonadism;   Peripheral Vascular Disease;   Type 2 Diabetes
Interventions: Drug: Testosterone;   Drug: 0.9% saline
2 Not yet recruiting Multi-spectral Imaging to Assess Wounds in Peripheral Vascular Disease Patients
Condition: Peripheral Vascular Disease Patient
Intervention: Device: Multi-spectral Imaging Device (MSID)
3 Unknown  Open-label Pilot Study to Assess the Use of Magic Foot™ in the Improvment of Parameters in Subject With Foot Symptoms
Conditions: Diabetes;   Peripheral Vascular Disease
Intervention: Device: Magic Foot™
4 Not yet recruiting Aclarubicin for the Treatment of Retinal Vasculopathy With Cerebral Leukodystrophy
Conditions: Vasculopathy, Retinal, With Cerebral Leukodystrophy;   Cerebroretinal Vasculopathy, Hereditary
Intervention: Drug: aclarubicin
5 Unknown  New Anastomotic Device for End to End Vascular Anastomosis in the Treatment of Peripheral Vascular Disease
Conditions: Peripheral Vascular Disease;   Femoral Occlusive Disease;   Femoropopliteal Occlusive Disease;   Aortoiliac Atherosclerosis
Intervention: Device: mechanical anastomosis without suture
6 Unknown  Safety Study of Using Stem Cells to Stimulate Development of New Blood Vessels in Peripheral Vascular Disease
Condition: Peripheral Vascular Diseases
Intervention: Drug: adult stem cells
7 Recruiting Shockwave Therapy in Lower Limb Intermittent Calf Claudication
Condition: Peripheral Vascular Disease
Intervention: Device: Extracorporeal shockwave therapy
8 Unknown  Intravitreal Bevacizumab for Polypoidal Choroidal Vasculopathy
Condition: Polypoidal Choroidal Vasculopathy
Intervention: Drug: Intravitreal Bevacizumab
9 Unknown  Safety Study of High-Dose Ranibizumab for Polypoidal Choroidal Vasculopathy
Condition: Polypoidal Choroidal Vasculopathy
Intervention: Drug: ranibizumab 2.0mg
10 Recruiting Safety and Efficacy of Everolimus - Eluting Bioresorbable Vascular Scaffold for Cardiac Allograft Vasculopathy
Condition: Cardiac Allograft Vasculopathy
Intervention: Device: Everolimus-Eluting Bioresorbable Vascular Scaffold (ABSORB)
11 Recruiting A Clinical and Histological Analysis of Mesenchymal Stem Cells in Amputation
Conditions: Ischemia;   Peripheral Arterial Disease;   Peripheral Vascular Disease;   Vascular Disease;   Arterial Occlusive Disease;   Arteriosclerosis;   Atherosclerosis;   Cardiovascular Disease;   Pathologic Processes;   Orthopedic Procedures;   Amputation
Intervention: Biological: Allogeneic bone marrow derived mesenchymal stem cells
12 Recruiting Using a Tailored Health Information Technology Driven Intervention to Improve Health Literacy and Medication Adherence
Conditions: Vascular Disease;   Cerebrovascular Disorders;   Ischemic Heart Disease;   Coronary Artery Disease
Intervention: Behavioral: Talking Rx
13 Recruiting A Phase IIB Pilot Study of a Modified Dosage Regimen of AMG0001 in Subjects With Critical Limb Ischemia
Conditions: Critical Limb Ischemia;   Vascular Diseases;   Peripheral Arterial Disease
Intervention: Genetic: HGF Plasmid
14 Recruiting Treatment of SFA Lesions With 480 Biomedical STANZA™ Drug-Eluting Resorbable Scaffold (DRS) System
Conditions: Peripheral Arterial Disease;   Intermittent Claudication;   Vascular Diseases;   Cardiovascular Diseases
Intervention: Device: STANZA Drug-eluting resorbable Scaffold
15 Recruiting Registry of the Magellan Robotic System
Condition: Peripheral Vascular Disease
Intervention:
16 Not yet recruiting Double-dose Ranibizumab for Polypoidal Choroidal Vasculopathy
Condition: Polypoidal Choroidal Vasculopathy
Interventions: Drug: Lucentis® (Raibizumab) double-dose;   Drug: Lucentis® (Raibizumab) regular-dose
17 Recruiting Adjuvant Benefit of NMES to Supervised Exercise in Patients With IC
Conditions: Intermittent Claudication;   Peripheral Vascular Disease;   Lower Limb Arterial Disease
Intervention: Device: Revitive IX
18 Recruiting Effects of Remote Ischemic Preconditioning on Restenosis Post Lower Limb Revascularization Angioplasty
Condition: Peripheral Vascular Diseases
Intervention: Other: Remote Ischemic Preconditioning
19 Unknown  Prostaglandin E1 (Liprostin) Treatment With Lower Limb Angioplasty for Peripheral Arterial Occlusive Disease
Condition: Peripheral Vascular Disease
Intervention: Drug: Liprostin [liposomal Prostaglandin E1]
20 Recruiting Intravitreal Aflibercept for Neovascular Polypoidal Choroidal Vasculopathy (RIVAL Trial)
Condition: Neovascular Polypoidal Choroidal Vasculopathy
Interventions: Drug: Rescue Intravitreal Aflibercept Injection;   Procedure: Rescue Therapy with PDT, Laser or Intravitreal Steroids

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years